Ann: Positive IHL-675A in vivo results and FDA Pathway, page-56

Hi Chaya and E ,
The results are excellent and there are a wide ranging anti inflammatory applications for the product that will be huge imo . They have Camargo on board as consultants who will process FDA Emergency Use Authorisation for which they have the credentials and experience . Very exciting times . We could not have hoped for a better outcome here . Exceptional news and I feel we will get significant MC traction once the market fully digests the enormity of the potential application of IHL-675A . We are well on the way to a new drug here . There are several other trials to come and further add to that the psychedelics strategy which is yet to be developed and announced and the potential here is very significant . The BOD is simply excellent and visionary and nimble in its ability to change tac and to position the company for success . Great work to the BOD and the entire team .
We now need to be patient and continue along for the ride . Still undervalued here IMO .